WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of TangenX® ...
WALTHAM, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced it has entered into an ...
Tangential Flow Filtration (TFF) is a crucial technology for manufacturing monoclonal antibodies (mAb), adeno-associated viruses (AAVs), and other biopharmaceuticals. However, challenges with ...
Novasign and Repligen entered into a strategic partnership to develop and integrate Novasign’s machine learning and modeling workflow into Repligen filtration systems. As part of the partnership, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback